iShares U.S. Pharmaceuticals ETF (IHE)

Delayed Data
As of 12:31pm ET
 +1.62 / +0.94%
Today’s Change
Today|||52-Week Range
IHE Regular Dividend: IHE began trading ex-dividend on 03/25/15. A $0.2554 dividend will be paid to shareholders of record as of 03/27/15.

Investment Objective

The investment seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It seeks to track the investment results of the Dow Jones U.S. Select Pharmaceuticals Index (the "underlying index"), which measures the performance of the pharmaceuticals sector of the U.S. equity market. The fund is non-diversified.

No recent news for iShares U.S. Pharmaceuticals ETF.


1 month+2.92% 3 years+29.50%
3 months+13.53% 5 years+25.56%
1 year+39.66% Since inception+16.60%
Data through 03/28/2015

Quote Details

Previous close$172.81
Open day’s range173.27 – 174.53
Net asset value (NAV)172.94 (03/27/2015)
Daily volume65,000
Average volume (3 months)63,201
Data as of 12:31pm ET, 03/30/2015

Peer Comparisonvs. Health ETFs

Performance 5-yr return+25.56%+22.29%
Expense Gross exp ratio0.45%0.47%
Risk 5 year sharpe ratio1.861.51
Net assets$1.0B$1.7B
Average market cap$17.7B$32.9B
Average P/E28.126.3
Dividend / Share--0.21%


XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Healthcare 98.99%
Consumer goods 1.01%
Business service 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
JNJ Johnson & Johnson7.76%
PFE Pfizer7.55%
MRK Merck6.46%
BMY Bristol-Myers Squibb5.61%
ACT Actavis5.42%
-- 5.16%
LLY Eli Lilly and Co4.78%
HSP Hospira Inc3.63%
ZTS Zoetis Inc3.47%
ENDP Endo International PLC3.34%

To view my watchlist

Not a member yet?

Sign up now for a free account